A Kher

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

L. Bara, Eliane M. Billaud, G. Gramond et al. · Thrombosis Research · 1985 · 192 citations

Hepatology, Medicine, Unfractionated Heparin +8

Once-daily Subcutaneous Dalteparin, a Low Molecular Weight Heparin, for the Initial Treatment of Acute Deep Vein Thrombosis

Jean‐Noël Fiessinger, María Fernanda López Fernández, E. Gatterer et al. · Thrombosis and Haemostasis · 1996 · 138 citations

Thrombosis, Subcutaneous Injections, Venous Thrombosis +15

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.

Martine Alhenc‐Gelas, C Jestin-Le Guernic, J.F. Vitoux et al. · PubMed · 1994 · 100 citations

Low-molecular-weight Heparin Fragmin, Deep Vein Thrombosis, Pharmacotherapy +18

Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis

Martine Alhenc‐Gelas, C. Jestin-Le Guernic, J.F. Vitoux et al. · Thrombosis and Haemostasis · 1994 · 95 citations

Low-molecular-weight Heparin Fragmin, Deep Vein Thrombosis, Pharmacotherapy +18

Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery

M Dechavanne, D Ville, M. Berruyer et al. · Pathophysiology of Haemostasis and Thrombosis · 1989 · 93 citations

Kabi 2165, Bilateral Venography, Interventional Radiology +23